Skip to main content

Orasure Technologies Inc 10-Q for FY2026 Q3

Orasure Technologies Inc (OSUR)

10-Q 2026-11-09 For: 2026-09-30
View Original
Added on November 09, 2026

About this 10-Q

Orasure Technologies Inc filed this 10-Q on November 9, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

OraSure Technologies reported net revenues of $30.9 million, up 14%, and an operating loss of $13.0 million versus $16.1 million. In June 2026, it received FDA 510(k) clearance for its Colli-Pee™•Dx Urine Collection Kit. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$30.91M
up 14.1% from $27.09M a year earlier
Net loss
$13.09M
compared with a net loss of $13.71M a year earlier
Diluted EPS
-$0.19
compared with -$0.19 a year earlier